Prelude Therapeutics

NASDAQ: PRLD · Real-Time Price · USD
0.84
-0.10 (-11.11%)
At close: Aug 15, 2025, 3:59 PM
0.87
4.05%
After-hours: Aug 15, 2025, 04:54 PM EDT

Prelude Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.76 -2.12 -2.67 -5.35
PEG Ratio
0.04 0.19 1.04 -0.07
PS Ratio
13.75 n/a n/a n/a
PB Ratio
0.73 1.09 1.46 2.07
P/FCF Ratio
-0.93 -2.33 -3.3 -6.9
P/OCF Ratio
-0.94 -2.41 -3.42 -7.09
OCF/S Ratio
-14.7 n/a n/a n/a
Debt / Equity Ratio
0.14 0.07 0.01 0.01
Quick Ratio
5.30 10.79 9.42 15.37
Current Ratio
5.30 10.79 9.42 15.37
Asset Turnover
0.04 n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.97 -0.51 -0.55 -0.39
Return on Assets
-0.72 -0.44 -0.49 -0.36
Return on Invested Capital
-0.92 -0.51 -0.57 -0.39
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 n/a n/a n/a
Net Profit Margin
-18.17 n/a n/a n/a
Pretax Profit Margin
-18.17 n/a n/a n/a
Operating Profit Margin
-19.96 n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-19.96 n/a n/a n/a